STAT3 and non-small cell lung carcinoma: Li et al. found that overexpressed miR-133b inhibits the proliferation of cisplatin-induced NSCLC cells through the regulation of the PI3K/Akt and JAK2/STAT3 signaling pathways by targeting epidermal growth factor receptor (EGFR) [65].